Skip to main content

Stanley C. Erck

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Stanley C. Erck

Earlier roles on record: CEO and Board Member at Novavax Inc (NVAX) until January 23, 2023. Novavax Inc reported in an 8-K filed January 9, 2023 that Stanley C. Erck retired as member of the Board, effective January 23, 2023. Novavax Inc reported in an 8-K filed January 9, 2023 that Stanley C. Erck retired as President and Chief Executive Officer, effective January 23, 2023. The proxy statement of Novavax Inc reports total compensation of $3,827,483 for Stanley C. Erck in fiscal 2023, including a base salary of $50,897. Disclosed compensation is on record for 7 fiscal years. Stanley C. Erck has spoken on 3 earnings calls across 1 company, most recently for Novavax Inc on March 1, 2022.

“Mr. Jacobs will succeed Stanley C. Erck, who provided the Board with notice on January 5, 2023 of his decision to retire as President and Chief Executive Officer and as a member of the Board, in each case effective as of January 23, 2023.”
Novavax Inc Form 8-K, filed January 9, 2023 · Read the filing
“Mr. Jacobs will succeed Stanley C. Erck, who provided the Board with notice on January 5, 2023 of his decision to retire as President and Chief Executive Officer and as a member of the Board, in each case effective as of January 23, 2023.”
Novavax Inc Form 8-K, filed January 9, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Novavax Inc (NVAX) $50,897 $3,827,483
2022 Novavax Inc (NVAX) $749,750 $8,401,283
2021 Novavax Inc (NVAX) $709,250 $1,118,030
2020 Novavax Inc (NVAX) $657,181 $48,086,018
2019 Novavax Inc (NVAX) $642,720 $2,438,562
2018 Novavax Inc (NVAX) $638,040 $4,158,398
2017 Novavax Inc (NVAX) $624,000 $2,771,685

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.